Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0004 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |